Truist Securities upgrades Astrana Health stock on strong value-based care demand By Investing.com

Business News
0
Please log in or register to do it.


On Thursday, Astrana Health, Inc (NASDAQ: ASTH) received an upgrade in its stock rating from a Truist Securities analyst. The rating was elevated from Hold to Buy, accompanied by an increase in the price target to $50.00, up from the previous target of $44.00. The upgrade comes as the analyst acknowledges Astrana Health’s ability to meet “pent-up” demand within the value-based care…



Your email address will not be published. Required fields are marked *

George Clooney juices Dems' rebellion against Biden
Zhang Lu to Head Busan Film Festival's Academy